Bone Material Strength Index As Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2021 Mar 29

PMID 33780545

Citations 4

Authors

Manuela Schoeb

Elizabeth M Winter

Maria A Sleddering

Mirjam A Lips

Abbey Schepers

Marieke Snel

Natasha M Appelman-Dijkstra

Affiliations

Soon will be listed here.

Abstract

Context: In primary hyperparathyroidism (PHPT) bone mineral density (BMD) is typically decreased in cortical bone and relatively preserved in trabecular bone. An increased fracture rate is observed however not only at peripheral sites but also at the spine, and fractures occur at higher BMD values than expected. We hypothesized that components of bone quality other than BMD are affected in PHPT as well.

Objective: To evaluate bone material properties using impact microindentation (IMI) in PHPT patients.

Methods: In this cross-sectional study, the Bone Material Strength index (BMSi) was measured by IMI at the midshaft of the tibia in 37 patients with PHPT (28 women), 11 of whom had prevalent fragility fractures, and 37 euparathyroid controls (28 women) matched for age, gender, and fragility fracture status.

Results: Mean age of PHPT patients and controls was 61.8 ± 13.3 and 61.0 ± 11.8 years, respectively, P = .77. Calcium and PTH levels were significantly higher in PHPT patients but BMD at the lumbar spine (0.92 ± 0.15 vs 0.89 ± 0.11, P = .37) and the femoral neck (0.70 ± 0.11 vs 0.67 ± 0.07, P = .15) were comparable between groups. BMSi however was significantly lower in PHPT patients than in controls (78.2 ± 5.7 vs 82.8 ± 4.5, P < .001). In addition, BMSi was significantly lower in 11 PHPT patients with fragility fractures than in the 26 PHPT patients without fragility fractures (74.7 ± 6.0 vs 79.6 ± 5.0, P = .015).

Conclusion: Our data indicate that bone material properties are altered in PHPT patients and most affected in those with prevalent fractures. IMI might be a valuable additional tool in the evaluation of bone fragility in patients with PHPT.

Citing Articles

Assessment of bovine cortical bone fracture behavior using impact microindentation as a surrogate of fracture toughness.

Jahani B, Vaidya R, Jin J, Aboytes D, Broz K, Krothapalli S JBMR Plus. 2024; 8(2):ziad012.

PMID: 38505533 PMC: 10945719. DOI: 10.1093/jbmrpl/ziad012.

Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter.

Lloret M, Fusaro M, Jorgensen H, Haarhaus M, Gifre L, Alfieri C J Clin Med. 2024; 13(4).

PMID: 38398323 PMC: 10889712. DOI: 10.3390/jcm13041010.

Mean Bone Material Strength Index Values for Women are Lower Than Those for Men: Data from a Single Geographical Location.

Holloway-Kew K, Rufus-Membere P, Anderson K, Harland J, Diez-Perez A, Kotowicz M Calcif Tissue Int. 2023; 113(5):511-514.

PMID: 37666992 PMC: 10618326. DOI: 10.1007/s00223-023-01133-9.

Secondary Osteoporosis and Metabolic Bone Diseases.

Sobh M, Abdalbary M, Elnagar S, Nagy E, Elshabrawy N, Abdelsalam M J Clin Med. 2022; 11(9).

PMID: 35566509 PMC: 9102221. DOI: 10.3390/jcm11092382.

References

Rufus-Membere P, Holloway-Kew K, Diez-Perez A, Kotowicz M, Pasco J . Associations Between Bone Impact Microindentation and Clinical Risk Factors for Fracture. Endocrinology. 2019; 160(9):2143-2150. DOI: 10.1210/en.2019-00415. View

Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R . MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019; 181(3):P1-P19. PMC: 6598862. DOI: 10.1530/EJE-19-0316. View

Diez-Perez A, Bouxsein M, Eriksen E, Khosla S, Nyman J, Papapoulos S . Technical note: Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation. Bone Rep. 2016; 5:181-185. PMC: 5152622. DOI: 10.1016/j.bonr.2016.07.004. View

Rozental T, Walley K, Demissie S, Caksa S, Martinez-Betancourt A, Parker A . Bone Material Strength Index as Measured by Impact Microindentation in Postmenopausal Women With Distal Radius and Hip Fractures. J Bone Miner Res. 2017; 33(4):621-626. DOI: 10.1002/jbmr.3338. View

Schoeb M, Hamdy N, Malgo F, Winter E, Appelman-Dijkstra N . Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature. Front Endocrinol (Lausanne). 2020; 11:15. PMC: 7020781. DOI: 10.3389/fendo.2020.00015. View

Cummings S, San Martin J, McClung M, Siris E, Eastell R, Reid I . Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009; 361(8):756-65. DOI: 10.1056/NEJMoa0809493. View

Bilezikian J, Cusano N, Khan A, Liu J, Marcocci C, Bandeira F . Primary hyperparathyroidism. Nat Rev Dis Primers. 2016; 2:16033. PMC: 5385896. DOI: 10.1038/nrdp.2016.33. View

Sosa D, Eriksen E . Reduced Bone Material Strength is Associated with Increased Risk and Severity of Osteoporotic Fractures. An Impact Microindentation Study. Calcif Tissue Int. 2017; 101(1):34-42. DOI: 10.1007/s00223-017-0256-5. View

Lalmohamed A, Welsing P, Lems W, Jacobs J, Kanis J, Johansson H . Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporos Int. 2011; 23(3):861-9. PMC: 3277691. DOI: 10.1007/s00198-011-1852-2. View

10.

Boonen S, Reginster J, Kaufman J, Lippuner K, Zanchetta J, Langdahl B . Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med. 2012; 367(18):1714-23. DOI: 10.1056/NEJMoa1204061. View

11.

Khan A, Hanley D, Rizzoli R, Bollerslev J, Young J, Rejnmark L . Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2016; 28(1):1-19. PMC: 5206263. DOI: 10.1007/s00198-016-3716-2. View

12.

Rokidi S, Bravenboer N, Gamsjaeger S, Misof B, Blouin S, Chavassieux P . Impact microindentation assesses subperiosteal bone material properties in humans. Bone. 2019; 131:115110. DOI: 10.1016/j.bone.2019.115110. View

13.

Bilezikian J . Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am J Med. 2009; 122(2 Suppl):S14-21. DOI: 10.1016/j.amjmed.2008.12.003. View

14.

Malgo F, Hamdy N, Papapoulos S, Appelman-Dijkstra N . Bone material strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of bone mineral density. J Clin Endocrinol Metab. 2015; 100(5):2039-45. DOI: 10.1210/jc.2014-4346. View

15.

Genant H, Wu C, van Kuijk C, Nevitt M . Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993; 8(9):1137-48. DOI: 10.1002/jbmr.5650080915. View

16.

Rubin M, Bilezikian J, McMahon D, Jacobs T, Shane E, Siris E . The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008; 93(9):3462-70. PMC: 2567863. DOI: 10.1210/jc.2007-1215. View

17.

Starr J, Tabacco G, Majeed R, Omeragic B, Bandeira L, Rubin M . PTH and bone material strength in hypoparathyroidism as measured by impact microindentation. Osteoporos Int. 2019; 31(2):327-333. DOI: 10.1007/s00198-019-05177-2. View

18.

Malgo F, Hamdy N, Papapoulos S, Appelman-Dijkstra N . Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site. Osteoporos Int. 2017; 28(8):2433-2437. PMC: 5524858. DOI: 10.1007/s00198-017-4054-8. View

19.

Schoeb M, Malgo F, Peeters J, Winter E, Papapoulos S, Appelman-Dijkstra N . Treatments of osteoporosis increase bone material strength index in patients with low bone mass. Osteoporos Int. 2020; 31(9):1683-1690. PMC: 7423791. DOI: 10.1007/s00198-020-05375-3. View

20.

Stein E, Silva B, Boutroy S, Zhou B, Wang J, Udesky J . Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res. 2012; 28(5):1029-40. PMC: 3631282. DOI: 10.1002/jbmr.1841. View